Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?

被引：15
作者：
Ostrosky-Zeichner, L [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, Houston, TX USA
来源：
CRITICAL CARE MEDICINE | 2004年 / 32卷 / 12期
关键词：
prophylaxis; preemptive therapy; invasive candidiasis; intensive care unit; surveillance cultures; risk;
D O I：
10.1097/01.CCM.0000148226.95597.7E
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2552 / 2553
页数：2
相关论文
共 20 条
  • [1] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
    Ascioglu, S
    Rex, JH
    de Pauw, B
    Bennett, JE
    Bille, J
    Crokaert, F
    Denning, DW
    Donnelly, JP
    Edwards, JE
    Erjavec, Z
    Fiere, D
    Lortholary, O
    Maertens, J
    Meis, JF
    Patterson, TF
    Ritter, J
    Selleslag, D
    Shah, PM
    Stevens, DA
    Walsh, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 7 - 14
  • [2] Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
    Blumberg, HM
    Jarvis, WR
    Soucie, JM
    Edwards, JE
    Patterson, JE
    Pfaller, MA
    Rangel-Frausto, MS
    Rinaldi, MG
    Saiman, L
    Wiblin, RT
    Wenzel, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) : 177 - 186
  • [3] Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
    Diekema, DJ
    Messer, SA
    Brueggemann, AB
    Coffman, SL
    Doern, GV
    Herwaldt, LA
    Pfaller, MA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1298 - 1302
  • [4] Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?
    Dupont, H
    Bourichon, A
    Paugam-Burtz, C
    Mantz, J
    Desmonts, JM
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (03) : 752 - 757
  • [5] Management of candida species infections in critically ill patients
    Eggimann, P
    Garbino, J
    Pittet, D
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (12) : 772 - 785
  • [6] Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients:: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
    Garbino, J
    Lew, DP
    Romand, JA
    Hugonnet, S
    Auckenthaler, R
    Pittet, D
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (12) : 1708 - 1717
  • [7] Attributable mortality of nosocomial candidemia, revisited
    Gudlaugsson, O
    Gillespie, S
    Lee, K
    Berg, JV
    Hu, JF
    Messer, S
    Herwaldt, L
    Pfaller, M
    Diekema, D
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) : 1172 - 1177
  • [8] EPIDEMIOLOGY OF NOSOCOMIAL FUNGAL-INFECTIONS, WITH EMPHASIS ON CANDIDA SPECIES
    JARVIS, WR
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (06) : 1526 - 1530
  • [9] Kullberg BJ, 2002, EUR J MED RES, V7, P183
  • [10] Systemic candidiasis in intensive care units: A multicenter, matched-cohort study
    Leleu, G
    Aegerter, P
    Guidet, B
    [J]. JOURNAL OF CRITICAL CARE, 2002, 17 (03) : 168 - 175
12